Additional file 3 of Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients

Additional file 3: Fig. S3 In vitro and in vivo carcinogenic potential of HNMT in BC cells. (A-B) MDA-MB-231 cells harboring HNMT siRNA (A) or overexpressing HNMT (B) were subjected to cell viability, migratory wound healing, and anchorage-independent growth soft agar assays. Invasion assay in MDA-MB-231 cells overexpressing HNMT (B). The irregular red lines in the migration assay images indicate wound healing areas. Western blot analysis confirmed the expression of the indicated proteins in MDA-MB 231 cells (231-Wt) and stable cells (231-Vc, 231-HN) (B). (C) On the left are bioluminescence images of 231-Wt-Luc, 231-Vc-Luc, and 231-HN-Luc tumor-bearing mice. Lung and tumor tissues from 231-Vc and 231-HN mice were collected after sacrifice for H&E staining to observe and quantify metastatic nodules. The representative H&E staining image on the right includes high-magnification images of 231-Vc and 231-HN tumor tissues highlighted in blue and red boxes, respectively. (D-E) Western blot analysis confirmed the expression of the indicated proteins in MDA-MB 231 cells (231-Wt), stable cells (231-Vc, 231-HN), primary cells derived from xenografted tumors (231-Vc-XE, 231-HN-XE), metastatic lung cancer cells (231-HN-LM) (D), and 231-HN cells harboring HNMT-scramble or HNMT-siRNA (E). (F) 231-HN and 231-Vc cells underwent RNA sequencing analysis (lower panel). We treated these cells with an E2F1-specific inhibitor (HLM006474, 40 μM for 24 h) and performed Western blot analysis to analyze the protein expression of T-AKT, using actin as a loading control (picture below). (G) We treated cells overexpressing HNMT (231-HN) and control cells (231-Vc) with EGF (100 ng/mL) for 24 h, and then performed RNA-Seq analysis. This data was consistent with previously published Genomic comparisons of PEDERSEN gene sets activated by PI3K/Akt or MAPK pathways in HER2+ tumors (NES = 1.24, P value = 0.04). The data are the means ± SEs. Statistical analysis was performed using a two-tailed unpaired Student's t-test. **P < 0.01 and ***P < 0.001. Scale bars = 250 µm (A, B) and 2 mm (C).

Institutions

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.28180960.v1
Primary Topic
Polyamine Metabolism and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Additional file 3 of Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients

Figshare
Polyamine Metabolism and Applications
article

Additional file 3 of Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients

article en

Abstract

Additional file 3: Fig. S3 In vitro and in vivo carcinogenic potential of HNMT in BC cells. (A-B) MDA-MB-231 cells harboring HNMT siRNA (A) or overexpressing HNMT (B) were subjected to cell viability, migratory wound healing, and anchorage-independent growth soft agar assays. Invasion assay in MDA-MB-231 cells overexpressing HNMT (B). The irregular red lines in the migration assay images indicate wound healing areas. Western blot analysis confirmed the expression of the indicated proteins in MDA-MB 231 cells (231-Wt) and stable cells (231-Vc, 231-HN) (B). (C) On the left are bioluminescence images of 231-Wt-Luc, 231-Vc-Luc, and 231-HN-Luc tumor-bearing mice. Lung and tumor tissues from 231-Vc and 231-HN mice were collected after sacrifice for H&E staining to observe and quantify metastatic nodules. The representative H&E staining image on the right includes high-magnification images of 231-Vc and 231-HN tumor tissues highlighted in blue and red boxes, respectively. (D-E) Western blot analysis confirmed the expression of the indicated proteins in MDA-MB 231 cells (231-Wt), stable cells (231-Vc, 231-HN), primary cells derived from xenografted tumors (231-Vc-XE, 231-HN-XE), metastatic lung cancer cells (231-HN-LM) (D), and 231-HN cells harboring HNMT-scramble or HNMT-siRNA (E). (F) 231-HN and 231-Vc cells underwent RNA sequencing analysis (lower panel). We treated these cells with an E2F1-specific inhibitor (HLM006474, 40 μM for 24 h) and performed Western blot analysis to analyze the protein expression of T-AKT, using actin as a loading control (picture below). (G) We treated cells overexpressing HNMT (231-HN) and control cells (231-Vc) with EGF (100 ng/mL) for 24 h, and then performed RNA-Seq analysis. This data was consistent with previously published Genomic comparisons of PEDERSEN gene sets activated by PI3K/Akt or MAPK pathways in HER2+ tumors (NES = 1.24, P value = 0.04). The data are the means ± SEs. Statistical analysis was performed using a two-tailed unpaired Student's t-test. **P < 0.01 and ***P < 0.001. Scale bars = 250 µm (A, B) and 2 mm (C).

Figshare
National Chung Hsing University (TW), National Taiwan University (TW), Duke University (US), Taichung Veterans General Hospital (TW), Taipei Medical University (TW), The Ohio State University (US), National Taipei University (TW)
Good health and well-being
Openalex Percentile: Top 61%
Polyamine Metabolism and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.